Almaty, Kazakhstan

Tattym E Shaikenov

This inventor holds 4 USPTO granted patents. Top assignee: International Phytochemistry Research Labs, Ltd.. Active years: 2000-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tattym E Shaikenov. Retrieved from https://idiyas.com/inventor/tattym-e-shaikenov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2000-2002

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Tattym E Shaikenov

Introduction

Tattym E Shaikenov is a prominent inventor based in Almaty, Kazakhstan. He has made significant contributions to the field of biochemistry, particularly in the development of farnesyl-protein transferase inhibitors. With a total of 4 patents to his name, Shaikenov's work is paving the way for advancements in cancer treatment.

Latest Patents

Shaikenov's latest patents focus on farnesyl-protein transferase inhibitors. These patents describe substantially pure preparations of phosphosesquiterpenes that inhibit farnesyl-protein transferase activity. The compounds developed by Shaikenov are particularly useful for the treatment of cancer. Additionally, methods for inhibiting farnesyl-protein transferase activity are also detailed in his patents.

Career Highlights

Tattym E Shaikenov is associated with International Phytochemistry Research Labs, Ltd., where he continues to innovate and contribute to the field of phytochemistry. His research has garnered attention for its potential applications in medical treatments.

Collaborations

Shaikenov collaborates with Sergazy M Adekenov, a fellow researcher who brings valuable insights and expertise to their joint projects.

Conclusion

Tattym E Shaikenov's work in developing farnesyl-protein transferase inhibitors represents a significant advancement in cancer treatment. His innovative spirit and dedication to research continue to inspire progress in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…